Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer

European Journal of Surgical Oncology

Volumn 36, Issue 1, 2010, Pages 58-64

  Karoui, M ^a   Soprani, A ^a   Charachon, A ^a   Delbaldo, C ^a   Vigano, L ^a   Luciani, A ^a   Cherqui, D ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Colonic stent; Irresectable stage IV colorectal cancer; Palliation; Primary chemotherapy

Indexed keywords

BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLON RESECTION; COLONIC STENT; COLORECTAL CANCER; DISEASE SEVERITY; FEMALE; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM RESECTION; STENT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; STENTS; SURVIVAL ANALYSIS;

EID: 73249138863     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.10.011     Document Type: Article

References (32)

1. Manfredi S., Lepage C., Hatem C., et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244 (2006) 254-259
2. Dixon M.R., and Stamos M.J. Strategies for palliative care in advanced colorectal cancer. Dig Surg 21 (2004) 344-351
3. Eisenberger A., Whelan R.L., and Neugut A.I. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis 23 (2008) 559-568
4. Scheer M.G., Sloots C.E., van der Wilt G.J., and Ruers T.J. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 19 (2008) 1829-1835
5. Rosen S.A., Buell J.F., Yoshida A., et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be?. Arch Surg 135 (2000) 530-534
6. Ruo L., Gougoutas C., Paty P.B., Guillem J.G., Cohen A.M., and Wong W.D. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196 (2003) 722-728
7. Galizia G., Lieto E., Orditura M., et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 143 (2008) 352-358
8. Scoggins C.R., Meszoely I.M., Blanke C.D., Beauchamp R.D., and Leach S.D. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6 (1999) 651-657
9. Sarela A.I., Guthrie J.A., Seymour M.T., Ride E., Guillou P.J., and O'Riordain D.S. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 88 (2001) 1352-1356
10. Tebbutt N.C., Norman A.R., Cunningham D., et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 52 (2003) 568-573
11. Michel P., Roque I., Di Fiore F., et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?. Gastroenterol Clin Biol 28 (2004) 434-437
12. Benoist S., Pautrat K., Mitry E., Rougier P., Penna C., and Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92 (2005) 1155-1160
13. Muratore A., Zorzi D., Bouzari H., et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy?. Ann Surg Oncol 14 (2007) 766-770
14. Evans M.D., Escofet X., Karandikar S.S., and Stamatakis J.D. Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer. World J Surg Oncol 7 (2009) 28
15. Poultsides G., Servais E., Saltz L., et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27 (2009) 3379-3384
16. Karoui M., Charachon A., Delbaldo C., et al. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 142 (2007) 619-623
17. Khot U.P., Lang A.W., Murali K., and Parker M.C. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 89 (2002) 1096-1102
18. Carne P.W., Frye J.N., Robertson G.M., and Frizelle F.A. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 47 (2004) 1455-1461
19. Fiori E., Lamazza A., Burza A., et al. Malignant intestinal obstruction: useful technical advice in self-expanding metallic stent placement. Anticancer Res 24 (2004) 3153-3155
20. Watt A.M., Faragher I.G., Griffin T.T., Rieger N.A., and Maddern G.J. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 246 (2007) 24-30
21. van Hooft J.E., Fockens P., Marinelli A.W., et al., Dutch Colorectal Stent Group. Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 40 (2008) 184-191
22. Hapani S., Chu D., and Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 10 (2009) 559-568
23. Karoui M., Koubaa W., Delbaldo C., et al. Chemotherapy has also an effect on primary tumor in colon carcinoma. Ann Surg Oncol 15 (2008) 3440-3446
24. Kabbinavar F.F., Hambleton J., Mass R.D., Hurwitz H.I., Bergsland E., and Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23 (2005) 3706-3712
25. Grothey A., Sugrue M.M., Purdie D.M., et al. Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE). J Clin Oncol 26 (2008) 5326-5334
26. Gruenberger B., Tamandl D., Schueller J., et al. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26 (2008) 1830-1835
27. Van Cutsem E., Köhne C.H., Hitre E., et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360 (2009) 1408-1417
28. Stelzner S., Hellmich G., Koch R., and Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 89 (2005) 211-217
29. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
30. Folprecht G., Grothey A., Alberts S., Raab H.R., and Köhne C.H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16 (2005) 1311-1319
31. Simmonds P.C., Primrose J.N., Colquitt J.L., Garden O.J., Poston G.J., and Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94 (2006) 982-999
32. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371 (2008) 1007-1016